| The impact of drug transporters on adverse drug reaction. | |
| | |
MedLine Citation:
|
PMID: 23338766 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
In this review, we have highlighted the adverse drug reaction mediated by transporters from two aspects: (1) competitive interactions between drug and drug/metabolite/endogenous substance mediated by transporters; (2) the expression/function change of transporter due to physiologic factors, disease, and drugs induction. It indicated that transporters exhibited a broad substrate specificity with a degree of overlap, which could change the pharmacokinetics of drugs and cause toxicity due to competition interactions among substrates. In addition, the expression and function of transporters were regulated by physiological conditions, pathological conditions, and drugs induction, which could cause adverse drug reaction and interindividual differences. Furthermore, one substrate was always medicated by several transporters and often subjected to metabolism by CYP enzymes, so we should be more aware of the increased plasma concentration of drugs caused by drug transporters as well as drug metabolizing enzymes synergistically, especially for drugs with narrow therapeutic window. In addition, the weightiness for one transporter to induce drugs plasma/tissue concentration change could be different in different condition. On the whole, transporters were corresponding with systemic/organs exposure of drug/metabolites/endogenous compounds. So understanding the expression and function in drug transporters will result in better strategies for optimal dosage regimen and reduce the risk for drug adverse reaction as well as adverse drug-drug interactions. |
| | |
Authors:
|
Yan Zhou; Guo-Qiang Zhang; Yu-Hui Wei; Jian-Ping Zhang; Guo-Rong Zhang; Jiang-Xia Ren; Hao-Gang Duan; Zhi Rao; Xin-An Wu |
Related Documents
:
|
23623086 - Pluronic f127 nanomicelles engineered with nuclear localized functionality for targeted... 7200306 - Electron microscopic studies on microfilariae of dipetalonema viteae and litomosoides c... 21491816 - Pharmacognostic research on viola tricolor l. (violaceae). 23295386 - Direct transcriptional regulation of human hepatic cytochrome p450 3a4 (cyp3a4) by pero... 23394386 - Institutional profile: institute of pharmacogenetics at the university hospital essen. 23227366 - Biodegradable in situ gel-forming controlled drug delivery system based on thermosensit... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-22 |
Journal Detail:
|
Title: European journal of drug metabolism and pharmacokinetics Volume: - ISSN: 0378-7966 ISO Abbreviation: Eur J Drug Metab Pharmacokinet Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7608491 Medline TA: Eur J Drug Metab Pharmacokinet Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pharmacy, First Hospital of Lanzhou University, Lanzhou, 730000, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Synthesis and characterization of heterocyclic disilylchalcogenides.
Next Document: Disposition and adjustment to chronic pain.